These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27502068)

  • 61. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
    Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
    Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.
    Aghssa MM; Tarafdari AM; Tehraninejad ES; Ezzati M; Bagheri M; Panahi Z; Mahdavi S; Abbasi M
    Reprod Health; 2015 Sep; 12():85. PubMed ID: 26357853
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.
    Baker VL; Gracia C; Glassner MJ; Schnell VL; Doody K; Coddington CC; Shin SS; Marshall LA; Alper MM; Morales AJ; Pavone ME; Behera MA; Zbella EA; Shapiro BS; Straseski JA; Broyles DL
    Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Can AMH levels predict the need for increased medication during IVF/ICSI in PCOS women?
    Kamel A; Ramadan W; Hussein AM; Dahab S; Elsherbini MM; Lasheen YS; Abu-Hamila F
    J Matern Fetal Neonatal Med; 2018 Jan; 31(1):32-38. PubMed ID: 27978775
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen.
    Freour T; Masson D; Dessolle L; Allaoua D; Dejoie T; Mirallie S; Jean M; Barriere P
    Arch Gynecol Obstet; 2012 Apr; 285(4):1177-82. PubMed ID: 22183426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
    Amer SA; Mahran A; Abdelmaged A; El-Adawy AR; Eissa MK; Shaw RW
    Reprod Biol Endocrinol; 2013 Dec; 11():115. PubMed ID: 24341292
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
    Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
    Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: A retrospective cohort study.
    Zheng H; Chen S; Du H; Ling J; Wu Y; Liu H; Liu J
    Medicine (Baltimore); 2017 Mar; 96(13):e6495. PubMed ID: 28353597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
    Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
    Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment.
    Sun TC; Zhou SJ; Song LL; Li JH; Chen X; Tian L
    JBRA Assist Reprod; 2021 Apr; 25(2):266-271. PubMed ID: 33710839
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
    Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of reproductive outcomes according to different serum anti-Müllerian hormone levels in females undergoing intracystoplasmic sperm injection.
    Brugo Olmedo S; De Vincentiis S; De Martino E; Bedecarrás P; Blanco AM; Freire A; Buffone MG; Rey RA
    PLoS One; 2013; 8(9):e75685. PubMed ID: 24069435
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
    Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ovarian stimulation with human and recombinant gonadotropin - comparison of in vitro fertilization efficiency with use of time-lapse monitoring.
    Wdowiak A; Bojar I
    Reprod Health; 2015 Dec; 12():113. PubMed ID: 26667662
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
    Andersen AN; Witjes H; Gordon K; Mannaerts B;
    Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
    Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
    Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF.
    Heidar Z; Bakhtiyari M; Mirzamoradi M; Zadehmodarres S; Sarfjoo FS; Mansournia MA
    J Endocrinol Invest; 2015 Sep; 38(9):1007-15. PubMed ID: 25981081
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.
    Fridén B; Sjöblom P; Menezes J
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):411-5. PubMed ID: 21988118
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.